Deep learning and disease detection
07 Apr 2022Marcel Gehrung, co-founder and CEO of rapidly growing Cambridge biotech company, Cyted, on revolutionising disease diagnostics and the challenges of building a business during a pandemic.
Marcel Gehrung, co-founder and CEO of rapidly growing Cambridge biotech company, Cyted, on revolutionising disease diagnostics and the challenges of building a business during a pandemic.
BKwai, a construction data company that helps engineers develop smarter, more sustainable infrastructure, has raised £2.2 million in seed funding from investors led by Octopus Ventures with participation from Cambridge Enterprise and Deeptech Labs.
'Enterprising mind', David Cleevely, one of the architects of Cambridge's world-leading innovation ecosystem, on the secrets of entrepreneurial success and why Cambridge is a great place to start a new venture.
A University of Cambridge spin-out company from the Cavendish Laboratory, combines materials engineering and cell biology to help biopharma companies make better medicines, faster. It announced today that it has closed a £2.14 million seed funding round.
Zero-carbon refrigeration pioneer Barocal has secured a £1.3 million investment to accelerate commercialisation of its novel technology designed to cut global CO₂ emissions. As the technology also works in heating applications, the University of Cambridge spin-out now plans to explore the potential of its breakthrough for domestic and commercial heating systems—to provide a cost-effective, efficient alternative to expensive air source heat pumps.
Meet the young biotech entrepreneur with two companies to her name and a plan to revolutionise the way we manage our health.
Connect: Health Tech, the University of Cambridge Enterprise Zone, has today launched a roadmap, ‘Creating a University Enterprise Zone for Cambridge across the life and physical sciences’, that examines the challenges faced in futureproofing and sustaining the growth of the life sciences cluster to maintain Cambridge as a global centre of excellence for health tech.
A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed at Cambridge hospitals, ahead of being launched in hospitals nationwide.